Filing Details
- Accession Number:
- 0001437749-19-000994
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-17 17:16:36
- Reporting Period:
- 2019-01-15
- Accepted Time:
- 2019-01-17 17:16:36
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1013237 | Factset Research Systems Inc | FDS | Services-Computer Programming, Data Processing, Etc. (7370) | 133362547 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1706225 | W. John Wiseman | C/O Factset Research Systems Inc. 601 Merritt 7 Norwalk CT 06851 | Evp, Global Head Of Sales | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-15 | 210 | $92.22 | 2,050 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 612 | $92.22 | 2,662 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 72 | $94.84 | 2,734 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 1,990 | $131.31 | 4,724 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 1,827 | $152.28 | 6,551 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 800 | $159.14 | 7,351 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-01-15 | 3,608 | $160.58 | 10,959 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-15 | 6,094 | $205.56 | 4,865 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-15 | 3,025 | $206.23 | 1,840 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-15 | 240 | $205.02 | 1,600 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-15 | 310 | $205.39 | 1,290 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-01-15 | 210 | $0.00 | 210 | $92.22 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-01-15 | 612 | $0.00 | 612 | $92.22 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-01-15 | 72 | $0.00 | 72 | $94.84 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-01-15 | 1,990 | $0.00 | 1,990 | $131.31 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-01-15 | 1,827 | $0.00 | 1,827 | $152.28 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-01-15 | 800 | $0.00 | 800 | $159.14 |
| Common Stock | Employee Stock Option (right to buy) | Disposition | 2019-01-15 | 3,608 | $0.00 | 3,608 | $160.58 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2022-11-01 | No | 4 | M | Direct | |
| 0 | 2022-11-01 | No | 4 | M | Direct | |
| 0 | 2021-11-01 | No | 4 | M | Direct | |
| 1,328 | 2024-11-03 | No | 4 | M | Direct | |
| 2,737 | 2026-11-01 | No | 4 | M | Direct | |
| 534 | 2025-05-01 | No | 4 | M | Direct | |
| 14,425 | 2027-07-06 | No | 4 | M | Direct |
Footnotes
- Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 6,094, the per share sales prices ranged from $205.10 to $206.09. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4.
- Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 3,025, the per share sales prices ranged from $206.10 to $206.48. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4.
- Price reported in Column 4 is a weighted average price based on various sales prices within a range. For the shares aggregating 310, the per share sales prices ranged from $205.38 to $205.51. The reporting person undertakes to provide FactSet, any security holder of FactSet and the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold in each separate price within the ranges set forth in this footnote to this Form 4.
- Options granted on November 1, 2012 vest over a 5 year period with 40% exercisable two years after the grant date and the remainder vesting at a rate of 1.67% per month thereafter.
- Options granted on November 1, 2012 vest over a 5 year period with 20% exercisable one year after the grant date and the remainder vesting at a rate of 1.67% per month thereafter.
- Options granted on November 1, 2011 vest over a 5 year period with 20% exercisable one year after the grant date and the remainder vesting at a rate of 1.67% per month thereafter.
- Options granted on November 3, 2014 vest over a 5 year period with 60% exercisable three years after the grant date and the remaining 40% vesting five years after the grant date.
- Options granted on November 1, 2016 vest 20% annually on the anniversary date of the grant and are fully vested after five years.
- Options granted on May 1, 2015 vest over a 5 year period with 60% exercisable three years after the grant date and the remaining 40% vesting five years after the grant date.
- Options granted on July 6, 2017 vest 20% annually on the anniversary date of the grant and are fully vested after five years.
Billionaire Hedge Funds
